Logo image
Back
α-Amino bisphosphonate triazoles serve as GGDPS inhibitors
Journal article   Peer reviewed

α-Amino bisphosphonate triazoles serve as GGDPS inhibitors

Nathaniel R. Gehrke, Dan Feng, Md. Ayub Ali, Mona A. Maalouf, Sarah A. Holstein and David F. Wiemer
Bioorganic & medicinal chemistry letters, Vol.102, pp.129659-129659
04/01/2024
DOI: 10.1016/j.bmcl.2024.129659
PMCID: PMC10981527
PMID: 38373465
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC10981527/pdf/nihms-1971886.pdfView
Open Access

Abstract

Depletion of cellular levels of geranylgeranyl diphosphate by inhibition of the enzyme geranylgeranyl diphosphate synthase (GGDPS) is a potential strategy for disruption of protein transport by limiting the geranylgeranylation of the Rab proteins that regulate intracellular trafficking. As such, there is interest in the development of GGDPS inhibitors for the treatment of malignancies characterized by abnormal protein production, including multiple myeloma. Our previous work has explored the structure-function relationship of a series of isoprenoid triazole bisphosphonate-based GGDPS inhibitors, with modifications having impact on enzymatic, cellular and in vivo activities. We have synthesized a new series of α-amino bisphosphonates to understand the impact of modifying the alpha position with a moiety that is potentially linkable to other agents. Bioassays evaluating the enzymatic and cellular activities of these compounds demonstrate that incorporation of the α-amino group affords compounds with GGDPS inhibitory activity which is modulated by isoprenoid tail chain length and olefin stereochemistry. These studies provide further insight into the complexity of the structure-function relationship and will enable future efforts focused on tumor-specific drug delivery.

Details

Metrics

1 Record Views
Logo image